Prospects for insulin delivery by ex-vivo somatic cell gene therapy

Journal of Molecular Medicine

Volumn 77, Issue 1, 1999, Pages 244-249

  Bailey, Clifford J ^a   Davies, Emma L ^a   Docherty, Kevin ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Genetic engineering; Insulin delivery; Insulin secreting non B cells; Somatic cell gene therapy

Indexed keywords

GLUCOSE; INSULIN; PROINSULIN;

CELL DESTRUCTION; CELL PROLIFERATION; CONFERENCE PAPER; CRYOPRESERVATION; FIBROBLAST; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SYNTHESIS; PANCREAS ISLET BETA CELL; SOMATIC CELL GENETICS;

EID: 0033009479     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050345     Document Type: Conference Paper

References (37)

1. 1. Zinman B (1989) The physiological replacement of insulin. An elusive goal. New Engl J Med 321: 363-370
2. 2. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329: 977-986
3. 3. Reach G (1992) Artificial and bioartificial replacement of the endocrine pancreas. Artificial Organs 16: 61-70
4. 4. Ricordi C (1996) Human islet cell transplantation: new perspectives for an old challenge. Diabetes Revs 4: 356-369
5. 5. Ferber S, Beltrandel Rio H, Johnson JH, Noel RJ et al (1994) Glut-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. Relationship to glucokinase activity. J Biol Chem 269: 11523-11529
6. 6. Newgard CB (1994) Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Diabetes 43: 341-350
7. 7. Efrat S (1996) Genetic engineering of B-cells for cell therapy of diabetes: cell growth, function, and immunogenicity. Diabetes Revs 4: 224-234
8. 8. Valera A, Fillat C, Costa C, Sabater J, Visa J, Pujol A, Bosch F (1994) Regulated expression of human insulin in the liver of transgenic mice corrects diabetes alterations. FASEB J 8: 440-447
9. 9. Kolodka TM, Finegold M, Moss L, Woo SLC (1995) Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc Nat Acad Sci USA 92: 3293-3297
10. 10. Docherty K (1991) Prospects for gene therapy and cellular engineering in diabetes. In: Pickup JC (ed) Biotechnology of insulin therapy. Oxford, Blackwell Scientific, pp 154-182
11. 11. Bailey CJ, Docherty K (1994) Exploring the feasibility of insulin gene therapy. In: Flatt PR, Lenzen S (eds) Insulin secretion and pancreatic B-cell research. London, Smith-Gordon, pp 613-620
12. 12. Lomedico PT (1982) Use of recombinant DNA technology to program eucaryotic cells to synthesize rat proinsulin - a rapid expression assay for cloned genes. Proc Natl Acad Sci USA 79: 5798-5803
13. 13. Laub O, Rutter WJ (1983) Expression of the human insulin gene and cDNA in a heterologous mammalian system. J Biol Chem 258: 6043-6050
14. 14. Moore H-PH, Walker MD, Lee F, Kelly RB (1983) Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35: 531-538
15. 15. Diatloff-Zito C, Papadopoulo D, Averbeck D, Moustacchi E (1986) Abnormal response to DNA crosslinking agents of Fanconi anaemia fibroblasts can be corrected by transfection with normal DNA. Proc Natl Acad Sci USA 83: 7034-7038
16. 16. Gross DJ, Villa-Komaroff L, Kahn CR, Weir GC, Halban PA (1989) Deletion of highly conserved tetrapeptide sequence of the proinsulin connecting peptide (C-peptide) inhibits proinsulin to insulin conversion by transfected pituitary cells. J Biol Chem 264: 21486-21490
17. 17. Selden RF, Skoskiewicz MJ, Russell PS, Goodman HM (1987) Regulation of insulin gene expression. Implications for gene therapy. N Engl J Med 317: 1067-1076
18. 18. Kawakami Y, Yamaoki T, Hirochika R, Yamashita K, Itakura M, Nakauchi H (1992) Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes 41: 956-961
19. 19. Stewart C, Taylor NA, Docherty K, Bailey CJ (1993) Insulin delivery by somatic cell gene therapy. J Mol Endocrinology 11: 335-341
20. 20. Stewart C, Taylor NA, Green IC, Docherty K, Bailey CJ (1994) Insulin-releasing pituitary cells as a model for somatic gene therapy in diabetes mellitus. J Endocrinol 142: 339-343
21. 21. Iwata H, Ogawa N, Takagi T, Mizoguchi J (1994) Preparation of insulin-releasing Chinese Hamster Ovary cell transfection of human insulin gene. Its implantation into diabetic mice. In: Shalaby SW, Ikada Y, Langer R, Williams J (eds) Polymers of biological and biomedical significance. Washington, American Chemical Society, pp 306-313
22. 22. Falqui L, Berra C, Severini GM, Martinengli S, Monti LD, Taglietti V, Pozza G, Bordignon C (1996) Production of mature human insulin by retrovirally engineered fibroblasts and primary rat hepatocytes. Exp Clin Endocrinol Diabetes 104: A37
23. 23. Blau HM, Springer ML (1995) Gene therapy - a novel form of drug delivery. N Engl J Med 333: 1204-1207
24. 24. Vollenweider F, Kaufmann J, Irminger JC, Halban PA (1995) Processing of proinsulin by furin, PC2, and PC3 in (co)transfected COS (monkey kidney) cells. Diabetes 44: 1075-1080
25. 25. Yanagita M, Hoshino H, Nakayama K, Takeuchi T (1993) Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines. Endocrinology 133: 639-644
26. 26. Groskrentz DJ, Sliwkowski MX, Gorman CM (1994) Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 269: 6241-6245
27. 27. Docherty K, Clark AR (1994) Nutrient regulation of insulin gene expression. FASEB J 8: 20-27
28. 28. Tiedge M, Hohne M, Lenzen S (1993) Insulin secretion, insulin content and glucose phosphorylation in RINm5F insulinoma cells after transfection with human GLUT2 glucose-transporter cDNA. Biochem J 296: 113-118
29. ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion: relationship to glucose metabolism. J Biol Chem 268: 15205-15212
30. 30. Hughes SD, Johnson JH, Quaade C, Newgard CB (1992) Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc Natl Acad Sci USA 89: 688-692
31. 31. Hohmeier HE, Beltrandel Rio H, Clark SA, Henkel-Rieger R, Normington K, Newgard CB (1997) Regulation of insulin secretion from novel engineered insulinoma cell lines. Diabetes 46: 968-977
32. 32. Davies EL, Docherty K, Shennan KIJ, Bailey CJ (1996) A gene therapy approach to create glucose-sensitive surrogate B-cells. Diabetic Medicine 13 [Suppl 1]: S9-S10
33. 33. Davies EL, Shennan KIJ, Docherty K, Bailey CJ (1996) Glucose-sensitive insulin-secreting AtT20 cells: a model for insulin delivery by somatic cell gene therapy. Diabetologia 39 [Suppl 1]: A137
34. 34. Docherty K, MacFarlane WM, Read ML, Smith SB, Wilson ME, Bujalska I, Gilligan M (1996) The regulation of insulin gene transcription by nutrients. Biochem Soc Trans 24: 368-372
35. 35. MacFarlane WM, Read ML, Gilligan M, Bujalska I, Docherty K (1994) Glucose modulates the binding activity of the β cell transcription factor IUF1 in a phosphorylation dependent manner. Biochem J 303: 625-631
36. 36. Mc Farlane W, Smith SB, Janies RSL, Clifton AD, Doza YN, Cohen P, Docherty K (1997) The p38/RK MAP kinase cascade mediates the activation of transcription factor IUF1 and insulin gene transcription by high glucose in pancreatic β-cells. J Biol Chem 272: 20936-20944
37. 37. Blau HM, Springer ML (1995) Muscle-mediated gene therapy. N Engl J Med 333: 1554-1556